Humanoid, Inc. (HERB)

ShockWave Medical Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Fiscal Year	Current	FY 2023	FY 2022	FY 2021	FY 2020	FY 2015
Period Ending	Aug 5, 2025	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2015
Market Capitalization	5	10	16	13	5	79
Market Cap Growth	-87.82%	-40.41%	29.00%	151.18%	-93.69%	-14.71%
Enterprise Value	-1	6	60	57	49	75
Last Close Price	0.03	0.06	0.10	0.08	0.03	0.51
PE Ratio	0.67	1.38	3.06	3.38	1.67	0.71
PS Ratio	0.22	0.46	0.87	0.90	0.40	0.09
PB Ratio	0.02	0.04	0.06	0.05	0.02	0.37
P/TBV Ratio	0.03	0.07	0.12	0.09	0.04	0.71
P/FCF Ratio	1.73	3.55	40.67	6.48	-	-
P/OCF Ratio	1.25	2.56	6.76	5.15	-	0.25
EV/Sales Ratio	-	0.27	3.25	4.06	3.93	0.08
EV/EBITDA Ratio	-	0.85	11.61	15.13	16.33	0.59
EV/EBIT Ratio	-	0.91	12.32	16.44	17.98	0.67
EV/FCF Ratio	-0.43	2.09	151.66	29.30	-	-
Debt / Equity Ratio	0.00	0.00	0.00	0.00	0.00	0.22
Debt / EBITDA Ratio	0.03	0.03	0.04	0.04	0.05	0.36
Debt / FCF Ratio	0.07	0.07	0.47	0.09	-	-
Asset Turnover	0.08	0.08	0.07	0.05	-	0.69
Inventory Turnover	6.09	6.09	5.16	2.71	-	4.78
Quick Ratio	1.88	1.88	1.68	2.02	1.57	1149.02
Current Ratio	2.71	2.71	2.49	3.34	3.28	1190.09
Return on Equity (ROE)	2.63%	2.63%	2.02%	1.42%	-	8.49%
Return on Assets (ROA)	1.44%	1.44%	1.15%	0.82%	-	5.16%
Return on Capital (ROIC)	1.47%	1.47%	1.17%	0.83%	-	5.23%
Return on Capital Employed (ROCE)	2.30%	2.30%	1.80%	1.30%	1.00%	43.80%
Earnings Yield	148.82%	72.59%	32.72%	29.56%	59.76%	140.96%
FCF Yield	57.71%	28.15%	2.46%	15.43%	-17.74%	-4.16%
Buyback Yield / Dilution	-	-	-	-	-	-1.33%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.